upadacitinib,linaclotide,risankizumab
Abbvie,ironwood pharmaceutical,Boehringer Ingelheim
['$abbv', 'abbvie']
$abbv abbvie releases new data demonstrating breadth of its gastroenterology portfolio at 2023 digestive disease week 
Stay ahead of the market with ultra-fast stock news updates. 
FREE with 15 sec delay. Upgrade to Gold for even faster news & exclusive features @ https://t.co/LViEqnfZ7i